Theravance, Inc. (THRX)
A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Recs
Klarman special
Recs
Best Bio Bets
Recs
short interest divergence from score of -68.77 and price of 15.84
Recs
Should underperform
Recs
There is no possible way to justify a market cap of $558 million for a company with negative equity and negative earnings.
Recs
Therevance appears to be a good company, but hit a rough spot. Should rebound from here.
Recs
Easiest way to find overvalued stocks go thru some biotechs.This one way overpriced Rev 20 Mil shares 60 mil. Insiders selling.Book value $1 . Muahhh look out below.My biotech shorts are outperforming. Get a basket of the worst ones and short.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 7 of 7